SENSEX NIFTY
Ranbaxy Laboratories

News from other websites on Ranbaxy Laboratories

Cadila recalls drug in US

Oct 18, 2014 at 20:22 | Source: Calcutta Telegraph News

Mumbai, Oct. 17: Cadila Healthcare has voluntarily recalled 5,400 bottles of anti-hypertension drug Atenolol tablets in the US for failing to meet specifications. A notification by the US Food and Drug Administration (USFDA) said the recall was volu...

Ranbaxy buys Texas peace

Oct 17, 2014 at 12:32 | Source: Calcutta Telegraph News

Mumbai, Oct. 16: Ranbaxy Laboratories today said it would pay $39.75 million (Rs 244 crore) to the state of Texas in the US to settle the litigation with regard to its participation in a social health scheme meant for the poor. “The company ha...

No CCI Directive to Sell Business For Merger Nod with Sun Pharma: Ranbaxy

Oct 16, 2014 at 23:59 | Source: NDTV Profit

New Delhi: Ranbaxy Laboratories, which is in the process of a $4 billion merger with Sun Pharma, said on Thursday the two firms as on date have not received any direction from the CCI to sell parts of their businesses as a pre-condition to approve th...

Ranbaxy to Pay $40 Million to Settle Texas Litigation

Oct 16, 2014 at 14:00 | Source: NDTV Profit

Mumbai: Generic drugmaker Ranbaxy Laboratories Ltd said it has agreed to pay $39.75 million to settle litigation concerning its participation in Texas Medicaid, the US federal-state healthcare program for people with low incomes. The litigation relat...

Ranbaxy Launches Acne Treatment Capsules in US

Oct 01, 2014 at 22:00 | Source: NDTV Profit

New Delhi: Drug firm Ranbaxy Laboratories on Wednesday launched a capsule used for treatment of severe acne in the US. Ranbaxy Laboratories Inc, a subsidiary of the company, has announced the launch of Absorica capsules in the strengths of 25 mg&...

Strides, Shasun pop merger pill

Sep 30, 2014 at 12:57 | Source: Calcutta Telegraph News

Mumbai, Sept: 29: Chennai-based Shasun Pharmaceuticals Ltd will be merged with generic drug maker Strides Arcolab to create a Rs 2,500-crore entity spanning across multiple segments. The merged entity will figure among the top 15 listed Indian pharm...

Corporate India s legal costs increase 17.5% in 2013-14

Sep 27, 2014 at 13:17 | Source: Economic Times

MUMBAI: An overhead cost is steadily expanding for Indian companies as they aggressively push in overseas markets and regulations become tougher at home and abroad. More than 1,800 listed companies that the ET Intelligence Group has analysed have col...

Drug firms get part price relief

Sep 24, 2014 at 04:47 | Source: Calcutta Telegraph News

New Delhi, Sept. 23: The government has withdrawn the national drug pricing authority’s power to set prices of non-essential medicines, but price caps on the over 100 non-essential drugs that drew the industry’s ire in July will remain. ...

Ranbaxy under US lens

Sep 18, 2014 at 04:37 | Source: Calcutta Telegraph News

Mumbai, Sept. 17: Ranbaxy Laboratories today said the US justice department had asked it to disclose the way it priced some drugs it sold in America. The Indian company, in fact, had made a provision of Rs 237.75 crore in the first quarter but had n...

Ranbaxy says U.S. authorities seek information on pricing data

Sep 18, 2014 at 00:45 | Source: FirstPost

MUMBAI (Reuters) - Generic drugmaker Ranbaxy Laboratories Ltd (RANB.NS) said on Wednesday that federal authorities in the United States had sought details on how it reports pricing data for some products eligible for reimbursement under the Medicaid ...

Ranbaxy Says US Authorities Seek Information on Pricing Data

Sep 17, 2014 at 19:57 | Source: NDTV Profit

Mumbai: Generics drug maker Ranbaxy Laboratories Ltd on Wednesday said federal authorities in the United States had sought details on how it reports pricing data for some products eligible for reimbursement under the Medicaid program. The company&...

Epirus, Ranbaxy Win India Approval for Arthritis Drug Copy

Sep 16, 2014 at 12:00 | Source: NDTV Profit

Epirus Biopharmaceuticals Inc said India's drug regulator has approved its copy of a top-selling arthritis treatment, paving the way for its launch in the country early next year. The company's Indian partner, Ranbaxy Laboratories Ltd...

US-Based Gilead Licenses Hepatitis C Drug to Cipla, Ranbaxy, 5 Others

Sep 15, 2014 at 16:00 | Source: NDTV Profit

New Delhi/Mumbai: US drug maker Gilead Sciences Inc on Monday said it has licensed its hepatitis C drug to seven companies including Cipla Ltd and Ranbaxy Laboratories Ltd to make it available in 91 developing countries including India....

Ranbaxy relief

Sep 14, 2014 at 12:02 | Source: Calcutta Telegraph News

Sept. 13 (Reuters): Pfizer Inc and Ranbaxy Laboratories on Friday won dismissal of a US anti-trust lawsuit accusing them of conspiring to delay sales of generic versions of the best-selling cholesterol drug Lipitor. US District Judge Peter Sheridan ...

Pfizer, Ranbaxy Win Dismissal of Lawsuit Over Generic Lipitor

Sep 13, 2014 at 12:00 | Source: NDTV Profit

Pfizer Inc and India's Ranbaxy Laboratories Ltd on Friday won dismissal of a US antitrust lawsuit accusing them of conspiring to delay sales of generic versions of the best-selling cholesterol drug Lipitor. US District Judge Peter Sheridan in...

CCI Says Sun's Takeover of Ranbaxy May Hurt Competition

Sep 04, 2014 at 20:00 | Source: NDTV Profit

Mumbai: India's antitrust regulator said on Thursday it had made an initial observation that Sun Pharmaceutical Industries Ltd's agreed $3.2 billion acquisition of Ranbaxy Laboratories Ltd could hurt competition, asking the companies ...

Ranbaxy Falls 2% on Reports of Rs 240 Crore US Fine

Aug 22, 2014 at 12:00 | Source: NDTV Profit

Shares in Ranbaxy Laboratories fell over 2 per cent on Friday after a newspaper report said that the state of Texas has imposed a fine of Rs 240 crore on the company. The fine, the report says, relates to slippages from the US-prescribed manufacturin...

Nifty retreats from record high on profit taking

Aug 21, 2014 at 00:51 | Source: FirstPost

MUMBAI (Reuters) - The Nifty edged lower on Wednesday, unable to sustain a rally after hitting a third consecutive record high earlier in session as investors took profits in blue-chips such as Oil and Natural Gas Corp(ONGC.NS).The falls ended a six-...

Pharma Shares Buck Stock Market Trend, Lead Gainers

Aug 20, 2014 at 16:00 | Source: NDTV Profit

Drug makers rose today bucking the stock market trend as investors seek defensives. Ranbaxy Laboratories was up 4 per cent, while Sun Pharmaceutical Industries gained 4.2 per cent after marking an all-time high of Rs 839. Glenmark Pharmaceuticals&...

Sun bid to address monopoly concern

Aug 14, 2014 at 04:07 | Source: Calcutta Telegraph News

Mumbai, Aug. 13: Sun Pharma today said it was in discussion with the Competition Commission of India (CCI) to allay apprehensions about the impact of its acquisition of Ranbaxy Laboratories on the domestic pharmaceutical sector. The fair trade watch...

video of the day

All portents good; optimistic for next few Diwali's: Damani

Explore Moneycontrol

Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.